Extendicare Inc. (TSE:EXE – Free Report) – Stock analysts at Leede Financial raised their FY2025 EPS estimates for shares of Extendicare in a research report issued on Thursday, November 28th. Leede Financial analyst D. Loe now expects that the company will post earnings per share of $1.33 for the year, up from their previous estimate of $1.29. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2026 earnings at $1.45 EPS and FY2027 earnings at $1.54 EPS.
Other analysts have also issued reports about the company. Royal Bank of Canada lifted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a report on Thursday, November 28th. TD Securities lifted their target price on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research note on Thursday, November 14th.
Extendicare Price Performance
Shares of TSE EXE opened at C$10.72 on Monday. The company has a market capitalization of C$894.80 million, a PE ratio of 15.76 and a beta of 1.26. The company has a quick ratio of 0.98, a current ratio of 0.60 and a debt-to-equity ratio of 305.80. The stock’s 50 day moving average price is C$9.58 and its 200-day moving average price is C$8.40. Extendicare has a twelve month low of C$6.63 and a twelve month high of C$10.79.
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were paid a $0.04 dividend. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $0.48 annualized dividend and a yield of 4.48%. Extendicare’s payout ratio is 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Further Reading
- Five stocks we like better than Extendicare
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Where to Find Earnings Call Transcripts
- Netflix Is On Track To Hit $1,000 By Christmas
- The How And Why of Investing in Oil Stocks
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.